Evidence map›Paper›PMID 31011231›Full record

ArticleBritish journal of cancer2019

Poor outcome in hypoxic endometrial carcinoma is related to vascular density.

Casper Reijnen, Willem Jan van Weelden, Martijn S J P Arts, Johan P Peters, Paul F Rijken, Koen van de Vijver, Maria Santacana, Peter Bronsert, Johan Bulten, Marc Hirschfeld and 21 more

Open access · hybridAbstract read
In one paragraph

Article in British journal of cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Endometrial carcinoma: use of tracer kinetic modeling of dynamic contrast-enhanced MRI for preoperative risk assessment.Cancer imaging : the official publication of the International Cancer Imaging Society · 2022
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 14 institutions in 8 countries.

Casper ReijnenDepartment of Obstetrics and Gynaecology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands. Casper.reijnen@radboudumc.nl.
Willem Jan van WeeldenDepartment of Obstetrics and Gynaecology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Martijn S J P ArtsDepartment of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Johan P PetersDepartment of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Paul F RijkenDepartment of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Koen van de VijverDepartment of Pathology, Ghent University Hospital, Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
Maria SantacanaDepartment of Pathology and Molecular Genetics and Research Laboratory, Hospital Universitari Arnau de Vilanova, University of Lleida, IRBLleida, CIBERONC, Lleida, Spain.
Peter BronsertInstitute of Pathology, University Medical Center, Freiburg, Germany.
Johan BultenDepartment of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
Marc HirschfeldDepartment of Obstetrics and Gynecology, University Medical Center, Freiburg, Germany.
Eva ColasBiomedical Research Group in Gynecology, Vall Hebron Institute of Research, Universitat Autònoma de Barcelona, CIBERONC, Barcelona, Spain.
Antonio Gil-MorenoBiomedical Research Group in Gynecology, Vall Hebron Institute of Research, Universitat Autònoma de Barcelona, CIBERONC, Barcelona, Spain.
Armando RequesPathology Department, Vall Hebron University Hospital, CIBERONC, Barcelona, Spain.
Gemma ManceboDepartment of Obstetrics and Gynecology, Hospital del Mar, PSMARB, Barcelona, Spain.
Camilla KrakstadDepartment of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.
Jone TrovikDepartment of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.
Ingfrid S HaldorsenCentre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway.
Jutta HuvilaDepartment of Pathology, University of Turku, Turku, Finland.
Martin KoskasObstetrics and Gynecology Department, Bichat-Claude Bernard Hospital, Paris, France.
Vit WeinbergerDepartment of Gynecology and Obstetrics, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Lubos MinarDepartment of Gynecology and Obstetrics, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Eva JandakovaInstitute of Pathology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Marc P L M SnijdersDepartment of Obstetrics and Gynaecology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.
Saskia van den Berg-van ErpDepartment of Pathology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.
Heidi V N Küsters-VandeveldeDepartment of Pathology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.
Xavier Matias-GuiuDepartment of Pathology and Molecular Genetics and Research Laboratory, Hospital Universitari Arnau de Vilanova, University of Lleida, IRBLleida, CIBERONC, Lleida, Spain.
Frederic AmantDepartment of Oncology, KU Leuven, Leuven, Belgium.
ENITEC-consortium
Leon F A G MassugerDepartment of Obstetrics and Gynaecology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Johan BussinkDepartment of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Johanna M A PijnenborgDepartment of Obstetrics and Gynaecology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Radboud University Nijmegen · NLRadboud University Medical Center · NLCanisius-Wilhelmina Ziekenhuis · NLCentro de Investigación Biomédica en Red de Cáncer · ESHaukeland University Hospital · NOMasaryk University · CZUniversity Medical Center Freiburg · DEBiomedical Research Institute of Lleida · ESGhent University Hospital · BEHospital Del Mar · ESKU Leuven · BEUniversitat de Lleida · ESUniversité Claude Bernard Lyon 1 · FRUniversity of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIdentification of endometrial carcinoma (EC) patients at high risk of recurrence is lacking. In this study, the prognostic role of hypoxia and angiogenesis was investigated in EC patients.

methodsTumour slides from EC patients were stained by immunofluorescence for carbonic anhydrase IX (CAIX) as hypoxic marker and CD34 for assessment of microvessel density (MVD). CAIX expression was determined in epithelial tumour cells, with a cut-off of 1%. MVD was assessed according to the Weidner method. Correlations with disease-specific survival (DSS), disease-free survival (DFS) and distant disease-free survival (DDFS) were calculated using Kaplan-Meier curves and Cox regression analysis.

resultsSixty-three (16.4%) of 385 ECs showed positive CAIX expression with high vascular density. These ECs had a reduced DSS compared to tumours with either hypoxia or high vascular density (log-rank p = 0.002). Multivariable analysis showed that hypoxic tumours with high vascular density had a reduced DSS (hazard ratio [HR] 3.71, p = 0.002), DDFS (HR 2.68, p = 0.009) and a trend for reduced DFS (HR 1.87, p = 0.054).

conclusionsThis study has shown that adverse outcome in hypoxic ECs is seen in the presence of high vascular density, suggesting an important role of angiogenesis in the metastatic process of hypoxic EC. Differential adjuvant treatment might be indicated for these patients.

Indexed as

AdultAgedAged, 80 and overCarbonic Anhydrase IXCell HypoxiaEndometrial NeoplasmsFemaleHumansMiddle AgedNeovascularization, PathologicCarbonic Anhydrase IX

Identifiers

PMID31011231
PMCPMC6738053
OpenAlexW2939348154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.